Regbex Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 1.68 Cr
as on 13-12-2024
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 74.45%
(FY 2022)
- Profit 154.98%
(FY 2022)
- Ebitda 157.58%
(FY 2022)
- Net Worth 18.86%
(FY 2022)
- Total Assets 26.68%
(FY 2022)
About Regbex Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.68 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kulandaivel Praveen, Sangeetha, Srinivasan Senthil, and Ten other members serve as directors at the Company.
- CIN/LLPIN
U24233TZ2016PTC022350
- Company No.
022350
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Mar 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Salem, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Regbex Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhandapani Vadamalai  | Managing Director | 13-Mar-2019 | Current |
Board Members(12)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sukumaran Sundaresan | Director | 13-Mar-2019 | Current |
| Kulandaivel Praveen | Director | 02-Mar-2016 | Current |
| Sangeetha | Director | 02-Mar-2016 | Current |
| Srinivasan Senthil | Director | 13-Mar-2019 | Current |
| Shadhashivam Kumar | Additional Director | 15-Jul-2020 | Current |
| Raghav Jayaseelan | Additional Director | 15-Jul-2020 | Current |
Financial Performance of Regbex Life Sciences.
Regbex Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 74.45% increase. The company also saw a substantial improvement in profitability, with a 154.98% increase in profit. The company's net worth Soared by an impressive increase of 18.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Regbex Life Sciences?
In 2022, Regbex Life Sciences had a promoter holding of 4.01% and a public holding of 95.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mara Ventures Private LimitedActive 3 years 5 monthsShadhashivam Kumar and Raghav Jayaseelan are mutual person
- Kvs Medical Center And Research Institute Private LimitedActive 8 years 6 months
Abboy Karunanithi is a mutual person
- Salem Medical Centre Hospital Private LimitedActive 24 years 7 months
Dhandapani Vadamalai is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Regbex Life Sciences?
Unlock and access historical data on people associated with Regbex Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Regbex Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regbex Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
